Peter Thompson, Terremoto Biosciences CEO
November 2, 2023 10:59 AM EDTUpdated 12:21 PM
Financing
Startups

Or­biMed and Third Rock’s Ter­re­mo­to Bio­sciences rais­es $175M for small mol­e­cule R&D

Kyle LaHucik

Senior Reporter

Ter­re­mo­to Bio­sciences has reeled in $175 mil­lion to cre­ate small mol­e­cules based on work from Prin­cip­ia Bio­phar­ma co-founder Jack Taunton and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times